ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Takeda Pharmaceuticals U.s.a., INC

Official 2024 U.S. DOL Form 5500 summary for Takeda Pharmaceuticals U.s.a., INC (Baxalta Incorporated And Subsidiaries Pension Plan · EIN 13-4013710 · PN 003): $392.92M net assets, 482 active participants, and $64.02 per $10,000 (64.02 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorTakeda Pharmaceuticals U.s.a., INC
Filing IdentifierBaxalta Incorporated And Subsidiaries Pension Plan · EIN 13-4013710 · PN 003
Plan Category & StateDefined Benefit & Cash Balance (PA)
Asset-Size Peer Cohort$100M-$500M
Plan Net Assets (2024)$392.92M
Active Participants482
Direct Admin Fee Rate$64.02 per $10,000 (64.02 bps)
Cohort Peer Median$9.75 per $10,000 (9.75 bps)
Primary Recordkeeper / ProviderWTW (Willis Towers Watson)
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI

Cross-Agency Entity Graph

Related Filings Across Meru Platforms

Verified federal filings reconciled for Takeda across sibling Meru AI platforms.